Create New Study

The Sentry® is Asentral, Inc. IRB's secure web portal used to exchange information safely between Asentral, Inc. IRB and its clients. Please complete the form below by entering all individuals who should be granted access to the study. Your submission will need to be reviewed and approved before it becomes active and accessible; once approved, all individuals associated with the study will be sent an email notifying them that they have been granted access to your study along with their login information.

We will send an e-mail confirmation to this e-mail address.

Companies

Please enter the Sponsor as the first company.

Company



Users
















Granted Access List: I understand that I am granting access of confidential information to the following users.

If necessary, please enter one CRO and use the remaining company fields to enter all Sites associated with this study.

Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Company



Users
















Add another site



Terms and Conditions

Thank you for choosing to use the Sentry®, the web portal of Asentral, Inc. Institutional Review Board (AIRB). By accessing the Sentry®, you accept these terms and conditions without limitation:

  1. Without limiting any of the foregoing, the content and functionality of the Sentry® is provided "AS IS" AND WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT.
  2. You agree that you will hold harmless and indemnify AIRB and its agents and officers from and against any damages based on your use of the Sentry®.




Your submission will need to be reviewed and approved before it becomes active and accessible; once approved, all individuals associated with the study will be sent an email notifying them that they have been granted access to your study along with their login information.


[ Cancel ]